Latest Transformation News

Opyl Limited has secured three key partnerships validating its AI-driven TrialKey platform, completed a strategic review to boost AI capabilities, and strengthened its balance sheet with a $1.5 million capital raise and Bitcoin investment.

Activeport Group has rapidly expanded its Network-as-a-Service platform, securing $3.2 million in contracts within two months of launch, signaling strong market demand for flexible fibre connectivity solutions.

Reward Minerals Limited is progressing its innovative potash processing technologies while simultaneously advancing exploration of its 100% owned Kalgoorlie gold projects, supported by a solid cash position of $1.738 million.

KGL Resources has leveraged cutting-edge integrated 3D inversion modelling to reveal multiple high-priority exploration targets at its Jervois and Unca Creek tenements, suggesting a larger and deeper mineral system than previously known.

Uvre Limited has secured a transformative portfolio of New Zealand gold projects, including the high-grade Waitekauri asset, backed by a $4 million capital raise and new board appointments. The company is gearing up for its maiden drilling campaign this September.

Alterity Therapeutics has secured U.S. FDA Fast Track designation for its drug ATH434 targeting Multiple System Atrophy, supported by promising Phase 2 clinical trial data showing slowed disease progression and a solid safety profile.

Codeifai Limited has raised $2.35 million through a share placement to fund key acquisitions and expand its footprint in quantum computing and AI. The move signals a strategic push towards U.S. market engagement and commercialisation of cutting-edge technology.

AdNeo Limited reports sustained positive cash flow and strong contract wins, advancing its strategic acquisition of Learnt Global ahead of schedule while securing $5.5 million in new capital.

Forrestania Resources has voluntarily suspended trading on the ASX as it prepares to announce a significant acquisition, signaling a potentially transformative move for the mining company.

Prescient Therapeutics has secured FDA Fast Track designation for PTX-100 in treating relapsed Cutaneous T-Cell Lymphoma and dosed the first patient in its Phase 2a trial, supported by a recent $6.8 million capital raise.

Bass Oil reported steady oil production and a significant cash reserve increase in the June quarter, while strategically acquiring the Vanessa gas field to pivot towards gas production.

TMK Energy has commenced drilling its seventh pilot well at the Gurvantes XXXV Coal Seam Gas Project, reporting positive reservoir pressure tests and advancing partnerships to fast-track development.